Delivery Order SPE2DB22D1103-SPE2DB24FTDK2
- Not listed
- The federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $3,069.05. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which operates under the Amerisourcebergen brand name. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by...
- The federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price of $13,347.25 and a ceiling value of $13,347.25. The contract has a period of performance through December 22, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $5,897.63. The contract is a Firm Fixed Price Delivery Order with a completion date of February 15, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which is the parent company. This contract is part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution and healthcare solutions provider, for a firm fixed price ceiling of $1,847.17. The contract has a January 24, 2024 completion date. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The contract is a delivery...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $4,371.74 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 28, 2023 with a completion date of December 29, 2023. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award is for the delivery of ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical program. The $17,821.19 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a firm fixed-price delivery order that runs through March 1, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $4,839.79, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of April 17, 2023 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets, with a ceiling value of $6,564.47. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a period of performance through February 5, 2024 and was awarded on February 2, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $1,212.49 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Both companies are...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $1,807.32 delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 31, 2021. The contract is a firm fixed-price Delivery Order with a completion date of September 1, 2021. AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTDK2Delivery Order
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,486.78 and is a firm fixed-price delivery order, with a period of performance running through January 4, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also a for-profit organization. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 1/3/24 |